D r Roman Jovey, a graduate of the University of Toronto (Toronto, Ontario) , was a general practitioner and emergency physician for almost 20 years. In 1999, he closed his family practice to focus on his evolving interest in chronic pain management and addiction medicine. He has been involved in pain management for 15 years and addiction medicine for the past 25 years.
He is currently the Program Director at CPM Health Centres Inc (Mississauga, Ontario), a group of outpatient chronic pain management clinics, as well as the Physician Director of the Credit Valley Hospital's Addictions and Concurrent Disorders Centre (Mississauga, Ontario) . He is the current President of the Canadian Pain Society. PA: A very difficult problem for a gastroenterologist is the long-term management of patients with chronic pain. Two of the most difficult categories of patients are those with Crohn's disease and those with chronic pancreatitis. Perhaps a few case discussions could illustrate your approach to these problems:
Case 1 -A 28-year-old woman has a 10-year history of Crohn's disease affecting the colon and small intestine. The disease is well documented with colonic biopsies showing typical granulomatous colitis. She has been put on steroids, methotrexate and infliximab, with only partial improvement in pain symptoms. She has had an ileocecal resection and continues to experience chronic abdominal pain. The patient is constantly asking for more oxycodone and is a 'frequent flier' in the local emergency room. She is an unemployed, single mother on chronic disability. RJ: This woman requires a detailed assessment of the evolution of her pain, her current pain description(s), previous and current response to medications, concurrent medical and psychiatric problems, as well as psychosocial contributors, including screening for risk factors for addiction. Ideally, such an assessment should be provided in an interdisciplinary pain program; however, these are scarce resources in Canada and the waiting times to attend such programs can vary from 18 months to four years. Because these patients do become 'frequent fliers' over time, health care professionals may tend to ignore changing symptoms and may miss a treatable cause of pain such as an incomplete bowel obstruction. She may benefit from a trial of a tricyclic antidepressant, titrated to analgesic effects or side effects. One would have to assess her use of immediaterelease/short-acting (IR/SA) oxycodone to decide if she would be better managed with a controlled-release/long-acting (CR/LA) opioid analgesic. Methadone can be a useful analgesic in such patients but requires a special prescribing authorization from Health Canada. PA: The gastroenterologist is often looking to reassess the activity of Crohn's disease by endoscopy, imaging and blood tests. It is often noted that the degree of pain seems out of proportion to the degree of disease activity. It is acknowledged that our tools may not be optimal, but this often leads to confrontation with or abandonment of the patient. RJ: The longer a patient suffers from any persistent pain problem, the more likely it is that he or she will develop central sensitization in the dorsal horn of the spinal cord and higher brain centres. This means that the severity of pain experienced is no longer directly related to the degree of peripheral stimulation of nociceptors by inflammation or other stimuli. Sensitized nociceptors are more 'twitchy' and more easily fired by any stimulation. This results in increased pain signalling in the central nervous system. However, pain does not always equate to suffering. Individual psychosocial factors such as mood changes, the meaning of the pain and the impact on ability to function influence the degree of suffering. PA: The gastroenterologist may fear that excess prescriptions of narcotics may lead to monitoring by the government, accusations of creating addiction by the patient, and legal problems associated with driving and work injuries. RJ: Part of a good medical practice is good documentation. This requires an appropriately documented history, physical examination, investigations, a diagnosis and differential diagnosis, a treatment plan and ongoing monitoring of any chronic condition. In the case of prescribing long-term opioids, physicians need to document an addiction screen monitor (Opioid Risk Tool) for any aberrant drug use behaviours and adjust treatment accordingly. The use of a written prescription agreement reduces the risk of being accused of iatrogenic addiction. The use of periodic, random urine drug testing for illicit substances may help in the early diagnosis of an evolving addiction problem. Increasing requests for IR/SA opioids to treat a chronic pain problem indicates that the patient should
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Dr Jovey can provide a copy of the Opioid Risk Tool and a Opioid Prescribing Agreement; he can be contacted through e-mail.
